Premium
Bone marrow Dikkopf‐1 levels are a new independent risk factor for progression in patients with smouldering myeloma
Author(s) -
Dalla Palma Benedetta,
Marchica Valentina,
Pedrazzoni Mario,
Accardi Fabrizio,
Notarfranchi Laura,
Goldoni Matteo,
De Luca Federica,
Costa Federica,
Storti Paola,
Toscani Denise,
Sammarelli Gabriella,
Bonomini Sabrina,
Aversa Franco,
Giuliani Nicola
Publication year - 2018
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15026
Subject(s) - multiple myeloma , medicine , lenalidomide , monoclonal gammopathy of undetermined significance , bone marrow , oncology , tumor progression , immunology , monoclonal , cancer , monoclonal antibody , antibody